吉林男科医院排名哪家比较好吉林左侧睾丸疼痛,吉林到哪个医院看早泄,吉林男科医院做包皮环切,吉林包皮过长治疗多少钱,吉林包皮切除,吉林阴茎背神经控敏术的副作用,吉林最好的前列腺炎是哪一种

WUHAN, China – The U.S. Centers for Disease Control (CDC) issued a level 3 travel warning Thursday for people visiting Wuhan, China.Under the warning, 163

SAN DIEGO (KGTV) -- A man police say rammed a patrol vehicle while holding a gun prompted an officer-involved shooting in North Park Saturday. The incident began around 9:20 p.m. when police received a call about a carjacking near Maryland Street and Madison Avenue. According to San Diego Police, the victim’s property, including a 2019 Subaru Outback, was taken at gunpoint. RELATED: Man arrested in officer-involved shooting sparked by pursuitPolice responded and found the vehicle on the 1800 block of Washington Street. When officers tried to stop the vehicle, the driver, a 17-year-old boy, fled the scene, leading police on a chase. The pursuit ended when the suspect drove off the road at Arizona Street and Howard Avenue before putting the car in reverse and driving toward officers. While backing up, police say the 17-year-old slouched down in the driver’s seat, pointing a handgun at police and prompting an officer to fire his weapon at the suspect. The man continued to back up, slamming into a patrol car, police say. RELATED: Investigating Officers: How SDPD investigates its own after an officer-Involved shooting“The suspect began revving the engine causing several officers to fear the suspect was about to go forward and run over the officer in front of the vehicle. The initial officer that fired, and one additional officer, fired their service weapons at the suspect,” police said. The suspect wasn’t hit with gunfire and surrendered to police. No officers were injured. At this time, the suspect isn’t being identified due to his age. The officers also aren’t being identified, but police say the first officer involved in the shooting is a one-year veteran of the department while the second is a two-year veteran. 1749

 Special counsel Robert Mueller's team on Friday slammed a suggestion by Michael Flynn's lawyers last week that President Donald Trump's former national security adviser lied to the FBI not even a month into his tenure because he was caught off guard when two agents approached him.However, Mueller's office said it would not change its recommendation that Flynn receive no jail time, given he has accepted responsibility for his actions and cooperated with the special counsel.Mueller on Friday also released memos written by the FBI agents, and emphasized that when Flynn lied to them on January 24, 2017, about the substance of his policy conversations with then-Russian Ambassador Sergey Kislyak, he had already lied to several members of Trump's team and was "committed to his false story" that he and Kislyak did not discuss sanctions.Flynn later said he had lied, and will be sentenced next week. 916

(AP) - With CBD showing up everywhere, U.S. regulators announced Tuesday they are exploring ways the marijuana extract could be used legally in foods, dietary supplements and cosmetics.The U.S. Food and Drug Administration said it will hold a public hearing May 31 to gather more information on the science, manufacturing and sale of cannabis compounds like CBD.In the meantime, it issued more warning letters to companies for making unapproved health claims about CBD products.Products containing CBD are already in stores and sold online, so it's easy to believe there must be something special about the ingredient. But the claims are largely unproven and quality control standards don't exist.RELATED: Can using CBD products cost someone their job? A look at what we know as U.S. regulators work out what will and won't be allowed:WHAT IS CBD?CBD is one of more than 100 compounds found in marijuana. It's extracted using alcohol or carbon dioxide in factories. It's added to oils, mixed into creams and lotions and sold in candies and liquid drops.Widely sold online, CBD now is going mainstream with major retailers offering salves and balms for the skin. Prices range from to 0 an ounce at high-end shops.CBD often comes from a cannabis plant known as hemp, which is defined by the U.S. government as having less than 0.3 percent THC. That's important because THC is what causes marijuana's mind-altering effect.CBD doesn't get people high, although it may be calming. Keep in mind some CBD products may contain THC, whether or not the label says so.RELATED: CBD-infused foods become rising trend in 2019People drug tested for work, addiction programs or because they take prescription opioids should take note: CBD products have caused people to fail urine drug screens.IS IT A MIRACLE CURE?If you believe the hype, CBD treats pain, relieves anxiety and both helps you sleep and keeps you focused.Most claims are based on studies in rats, mice or in test tubes. Some human research has been done, but in small numbers of people.One exception: For two rare seizure disorders, the evidence for CBD was strong enough to convince the FDA to approve GW Pharmaceutical's drug Epidiolex, which contains a purified form.The FDA announced Tuesday it has sent warning letters to three companies marketing products with what outgoing Commissioner Scott Gottlieb called "egregious, over-the-line claims" for CBD's effects on cancer, Alzheimer's disease, fibromyalgia and drug addiction. Gottlieb said the agency "won't tolerate this kind of deceptive marketing to vulnerable patients."RELATED: CVS Pharmacy selling cannabis-based products in stores in California, 7 other statesOnly drugs that have been reviewed by the FDA as safe and effective can make claims that they treat or prevent diseases or medical conditions. Many CBD producers attempt to sidestep the issue by using only vague language about general health and well-being.ANY SIDE EFFECTS?Scant research means not much is known about side effects either. In epilepsy research, CBD changed the way the body processed other drugs. That suggests CBD could interact with medications in ways we still don't know about.The most common side effects of the CBD drug Epidiolex include sleepiness, decreased appetite, diarrhea, increases in liver enzymes, exhaustion, rash and infections. FDA's Gottlieb noted Tuesday the potential for liver injury and other risks can be handled with medical supervision but less is known about how that would be managed without oversight. And there are questions about overlap if multiple CBD products are used.IS IT LEGAL?For now, the agency has said CBD is not allowed as an ingredient in food, drinks or dietary supplements.In stating its position, the FDA cited a provision of the law prohibiting food makers from using active drug ingredients or those that are the subject of substantial research. But the agency doesn't have the resources to police all the CBD products that are already available, said Marc Scheineson, a former FDA official.RELATED: Creator of Jelly Belly releases CBD-infused jelly beans"They're not going to pull a thousand products from the market," he said.The FDA's authority is over interstate commerce, and local officials have taken differing approaches. In New York, Los Angeles and elsewhere, officials are warning eateries to stop selling it in food and drinks. Maine passed a law allowing it in foods and other products in the state.Skin creams and cosmetics may be on safer footing with the FDA, but that too remains uncertain, said Camille Gourdet of RTI International, a nonprofit research institute in Durham, North Carolina. Though cosmetics aren't subject to premarket approval by the FDA, they could run afoul of regulations if they make specific health claims.Marijuana itself is illegal under federal law; most states that have legalized it allow marijuana-infused foods and candies, called edibles.ARE CBD LABELS ACCURATE?What you buy may contain much less CBD than the label states — or much more. It may include more THC than you want and it may be contaminated with mold or pesticides. Ask to see testing reports.A 2017 study in the Journal of the American Medical Association found 70 percent of CBD products were mislabeled. Researchers used an independent lab to test 84 products from 31 companies."You're really flying by the seat of your pants when you buy this stuff," said author Marcel Bonn-Miller of University of Pennsylvania.A product labeled as containing 100 milligrams of CBD may only have 5 milligrams or it may have 200, said Bonn-Miller, now an adviser for a company that sells CBD and other cannabis products. He did not work in the industry when he did the research."I wouldn't trust any of it until I knew independently it was safe," Bonn-Miller said.WHAT'S AHEAD?CBD research is planned or underway for cancer, autism, diabetic neuropathy, fibromyalgia, chronic pain, alcoholism with PTSD and psychiatric conditions. Results will take years, but some people aren't waiting."They are vulnerable and really hoping to feel better," said Karen Hande, a nurse practitioner at Vanderbilt-Ingram Cancer Center in Nashville.She became an expert in CBD because so many of her cancer patients were trying it. She tells them the evidence isn't enough to back the claims, but "they want to believe something is going to work." 6383

"Black Bear" is a proudly weird film that shakes up the formula to the point that it explodes like a soda left in the fridge.The experimental film's fortunes rise and fall around the dryly comic talents of Aubrey Plaza, who delivers in a major way, exploring the playful cruelty she's subtly hinted at in many of her comedic roles.Plaza explores her dark side as Allison, a manipulative actress, and filmmaker who rents a home from Blair (Sarah Gordon) and her husband, Gabe (Christopher Abbott) to shoot a mysterious new project. She quickly inserts herself into their personal disputes, taking a sadistic pleasure in driving a wedge between the couple with subtle insults and provocations.Allison sees people as her playthings, and freely spins lies, half-truths, and seductive inferences, slithering in and out of suspicion, trust, hostility, and feigned kindness toward her mysterious goals. The interplay between Allison, Gabe, and Blair was enough to carry the movie, which would have been better suited had it stuck with the theme to its bitter end.Instead, the script flips just as the intensity level simmers.Writer/director Lawrence Michael Levine divides the film into two parts. The first is a captivating psychological game, but the second seems like a slew of barely-connected outtakes in which actors have swapped roles.While the scenes are often fascinating as they stand alone, they don't coalesce into much of a unified purpose. If the goal was to satirize the art of filmmaking or play with the quirks of the actor-director-writer dynamic, the result is a convoluted mess. Whatever inside jokes or buried subtext Levine were going for just doesn't translate.The title, which is no doubt some sort of opaque metaphor, also refers to a literal bear who just shows up, because, well, why not? Once Levine has stripped his project of any sense of cohesion, just about anything goes. If his goal was to show how a promising artistic project can derail, he succeeds too mightily.RATING: 2.5 stars out of 4.Phil Villarreal TwitterPhil Villarreal FacebookPhil Villarreal Amazon Author PagePhil Villarreal Rotten Tomatoes 2143